NewLink Genetics Corporation | Lumos Pharma | Iowa | state | 2007 | $49,130 | | training reimbursement |
Abraxis BioScience, LLC | Bristol-Myers Squibb | Iowa | state | 2009 | $116,970 | | training reimbursement |
Abraxis BioScience, LLC | Bristol-Myers Squibb | Iowa | state | 2010 | $158,808 | | training reimbursement |
BioProtection Systems Corporation | Lumos Pharma | Iowa | state | 2007 | $71,101 | | training reimbursement |
NewLink Genetics Corporation | Lumos Pharma | Iowa | state | 2011 | $55,629 | | training reimbursement |
NewLink Genetics Corporation | Lumos Pharma | Iowa | state | 2008 | $57,716 | | training reimbursement |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | Iowa | state | 2012 | $3,239,000 | | grant |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | Iowa | state | 2012 | $1,944,528 | | tax credit/rebate |
Boehringer Ingelheim Vetmedica Inc. | Eli Lilly | Iowa | state | 2014 | $506,133 | | tax credit/rebate |
Cambrex Charles City, Inc | Cambrex | Iowa | state | 2012 | $537,648 | | tax credit/rebate |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | Iowa | state | 2010 | $5,275,484 | | tax credit/rebate |
Boehringer Ingelheim Vetmedica Inc. | Eli Lilly | Iowa | state | 2015 | $516,584 | | tax credit/rebate |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2015 | $1,330,020 | | tax credit/rebate |
Zoetis, Inc. and Subsidiaries | Zoetis | Iowa | State | 2017 | $2,499,000 | | Tax credit |
Cambrex Charles City, Inc. | Cambrex | Iowa | State | 2017 | $300,898 | | grant/loan hybrid program |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2020 | $494,275 | | grant/loan hybrid program |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2020 | $458,408 | | training reimbursement |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2017 | $502,233 | | training reimbursement |
Elanco Us Inc. | Elanco Animal Health | Iowa | state | 2015 | $684,174 | | training reimbursement |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2014 | $740,512 | | training reimbursement |
Newlink Genetics Corporation | Lumos Pharma | Iowa | state | 2014 | $200,071 | | training reimbursement |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2013 | $318,203 | | training reimbursement |
Eli Lilly | Eli Lilly | Indiana | multiple | 1999 | $214,000,000 | | MEGADEAL |
Kremers Urban Pharmaceuticals Inc. | Lannett Co. | Indiana | state | 2010 | $1,250,000 | | tax credit/rebate |
Roche Diagnostics Operations, Inc. | Roche | Indiana | state | 2012 | $2,000,000 | | tax credit/rebate |
Albany Molecular Research, Inc. | Curia Inc. | Indiana | state | 2013 | $350,000 | | tax credit/rebate |
Eli Lilly dba Elanco Animal Health | Eli Lilly | Indiana | state | 2013 | $500,000 | | grant |
Disetronic Medical Systems, Incorporated | Roche | Indiana | state | 2005 | $20,000 | | training reimbursement |
Bristol-Myers Squibb Co. dba Mt. Vernon Technical Operations | Bristol-Myers Squibb | Indiana | state | 2007 | $101,500 | | training reimbursement |
Roche Diagnostics Operations, Inc. | Roche | Indiana | state | 2008 | $200,000 | | training reimbursement |
Kremers Urban Pharmaceuticals Inc. | Lannett Co. | Indiana | state | 2009 | $310,000 | | training reimbursement |
Bristol-Myers Squibb Co. dba Mt. Vernon Technical Operations | Bristol-Myers Squibb | Indiana | state | 2009 | $137,500 | | training reimbursement |
Roche Diagnostics Operations, Inc. | Roche | Indiana | state | 2010 | $50,000 | | training reimbursement |
Kremers Urban Pharmaceuticals Inc. | Lannett Co. | Indiana | state | 2011 | $200,000 | | training reimbursement |
Roche Diagnostics Operations, Inc. | Roche | Indiana | state | 2012 | $300,000 | | training reimbursement |
Albany Molecular Research, Inc. | Curia Inc. | Indiana | state | 2012 | $50,000 | | training reimbursement |
General Nutrition Corporation | Harbin Pharmaceutical Group | Indiana | state | 2014 | $1,050,000 | | tax credit/rebate |
General Nutrition Corporation | Harbin Pharmaceutical Group | Indiana | state | 2014 | $200,000 | | training reimbursement |
AstraZeneca Pharmaceuticals LP | AstraZeneca | Indiana | state | 2017 | $600,000 | | tax credit/rebate |
AstraZeneca Pharmaceuticals LP | AstraZeneca | Indiana | state | 2017 | $200,000 | | training reimbursement |
Johnson & Johnson Health Care Systems Inc. | Johnson & Johnson | Indiana | state | 2020 | $2,250,000 | | tax credit/rebate |
Johnson & Johnson Health Care Systems Inc. | Johnson & Johnson | Indiana | state | 2010 | $300,000 | | tax credit/rebate |
Elanco Animal Health Inc | Elanco Animal Health | Indiana | multiple | 2020 | $163,100,000 | | MEGADEAL |
Elanco Us Inc. | Elanco Animal Health | Indiana | state | 2021 | $9,750,000 | | tax credit/rebate |
Elanco Us Inc. | Elanco Animal Health | Indiana | state | 2021 | $12,000,000 | | tax credit/rebate |
Elanco Us Inc. | Elanco Animal Health | Indiana | state | 2021 | $2,000,000 | | tax credit/rebate |
Elanco Us Inc. | Elanco Animal Health | Indiana | state | 2021 | $2,000,000 | | tax credit/rebate |
Eli Lilly & Company | Eli Lilly | Indiana | state | 2022 | $293,100,000 | | MEGADEAL |
Abbott Laboratories | Abbott Laboratories | Illinois | state | 2004 | undisclosed | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2004 | undisclosed | | tax credit/rebate |
Abbott Laboratories | Abbott Laboratories | Illinois | state | 2005 | $378,187 | | tax credit/rebate |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | Illinois | state | 2005 | undisclosed | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2005 | undisclosed | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2005 | undisclosed | | tax credit/rebate |
Abbott Laboratories | Abbott Laboratories | Illinois | state | 2006 | $381,909 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Illinois | state | 2006 | $1,060,334 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2006 | undisclosed | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2006 | undisclosed | | tax credit/rebate |
Abbott Laboratories | Abbott Laboratories | Illinois | state | 2007 | $409,371 | | tax credit/rebate |
Astellas Research Institute of America | Astellas Pharma | Illinois | state | 2007 | undisclosed | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Illinois | state | 2007 | $1,060,334 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2007 | $1,385,605 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2007 | undisclosed | | tax credit/rebate |
Abbott Laboratories | Abbott Laboratories | Illinois | state | 2008 | $485,631 | | tax credit/rebate |
Astellas Research Institute of America | Astellas Pharma | Illinois | state | 2008 | undisclosed | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Illinois | state | 2008 | $1,605,983 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2008 | $2,872,836 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2008 | $2,034,824 | | tax credit/rebate |
Astellas Research Institute of America | Astellas Pharma | Illinois | state | 2009 | $62,980 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Illinois | state | 2009 | $1,605,983 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2009 | $4,511,785 | | tax credit/rebate |
Astellas Research Institute of America | Astellas Pharma | Illinois | state | 2010 | $96,488 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Illinois | state | 2010 | $1,605,983 | | tax credit/rebate |
Lundbeck Inc. | Lundbeck | Illinois | state | 2010 | undisclosed | | tax credit/rebate |
Apotex Corporation | Apotex Corp. | Illinois | state | 2004 | $22,500 | | grant |
Astellas US Holding, Inc | Astellas Pharma | Illinois | state | 2005 | $137,500 | | grant |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2005 | $196,965 | | grant |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2005 | $196,965 | | grant |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2005 | $200,000 | | grant |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2005 | $200,000 | | grant |
Astellas US Holding, Inc | Astellas Pharma | Illinois | state | 2006 | $87,250 | | grant |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2006 | $350,000 | | grant |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2007 | $350,000 | | grant |
Astellas US Holding, Inc | Astellas Pharma | Illinois | state | 2008 | $30,000 | | grant |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2004 | $100,000 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2005 | $1,000,000 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2005 | $952,634 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2006 | $1,250,000 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2006 | $1,384,120 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2007 | $404,000 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2007 | undisclosed | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2008 | $668,300 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2008 | undisclosed | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2009 | $1,105,019 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2005 | $3,000,000 | | grant |
Astellas US Holding, Inc | Astellas Pharma | Illinois | state | 2007 | $500,000 | | grant |
McNeil Consumer Healthcare Division of McNEll-PPC, | Johnson & Johnson | Illinois | state | 2013 | $105,502 | | tax credit/rebate |
ABRAXIS BIOSCIENCE LLC | Bristol-Myers Squibb | Illinois | local | 2012 | undisclosed | | property tax abatement |
Astellas US LLC and its subsidiaries and related entities | Astellas Pharma | Illinois | state | 2014 | $3,398,678 | | tax credit/rebate |
Astellas US LLC and its subsidiaries and related entities | Astellas Pharma | Illinois | state | 2013 | $1,383,958 | | tax credit/rebate |
Astellas US LLC and its subsidiaries and related entities | Astellas Pharma | Illinois | state | 2015 | $3,701,242 | | tax credit/rebate |